Dr. John Joseph Nemunaitis MD
Oncologist | Medical Oncology
3410 Worth St Dallas TX, 75246About
Dr. John Nemunaitis is an oncologist practicing in Dallas, TX. Dr. Nemunaitis specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Nemunaitis manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Gene therapy for head and neck cancers.
- RhGM-CSF in bone marrow transplantation: experience in pediatric patients.
- Cancer treatment involving oncolytic viruses.
- mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
- Lung cancer vaccines.
- Are vaccines making a comeback in non-small-cell lung cancer?
- Compassionate approval process for experimental gene-based products.
- The use of recombinant human granulocyte macrophage colony-stimulating factor in autologous bone marrow transplantation.
- Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.
- Synthetic vs. natural/biodegradable polymers for delivery of shRNA-based cancer therapies.
- Gene immunotherapy for non-small cell lung cancer.
- Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
- Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.
- First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
- A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies.
Clinical Trials
- Study of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
- Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
- Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors
- pIL-12 and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment
- Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer
- Study of DPX-Survivac Vaccine Therapy and Epacadostat in Patients With Recurrent Ovarian Cancer
- Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
- MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
- Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
- Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
- Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
Dr. John Joseph Nemunaitis MD's Practice location
Practice At 3410 Worth St
3410 Worth St -Dallas, TX 75246Get Direction
Practice At 3535 Worth St Suite 302
3535 Worth St Suite 302 -Dallas, TX 75246Get Direction
Dr. John Joseph Nemunaitis MD's reviews
Write ReviewRecommended Articles
![]()
The Different Stages of Bladder CancerWhat Are the Different Stages of Bladder Cancer?When coming up with a suitable treatment process with a doctor, you begin by staging your disease. Staging bladder cancer is one of the most critical factors considered when making decisions on treatment options. Your health care providers use...
![]()
When Should I Get Checked for Prostate Cancer?Prostate cancer is more likely to occur in men aged between forty and seventy years old. It is, therefore, important that you should always be on alert in case any symptoms begin to show. This prompts a visit to the doctor within the quickest possible time.Deciding on whether or not to be screened...
![]()
What Impact Does Hospital Volume Have on Ovarian Cancer Survival?Ovarian cancer is one of the most difficult cancers to treat. Though overall survival is generally over 90% if caught early, only about 15% of ovarian cancers are diagnosed at early stages. This means that many women are diagnosed with ovarian cancer at more advanced stages with high mortality.With...
![]()
Ovarian Cancer: The Cliché About Cancer That’s TrueLast June, 24-year-old Dani Strumeier, a tax accountant at PwC, began to experience pain in her lower abdomen, but she brushed off going to the hospital because she knew that there would be needles there. She could not have blood drawn from her body without throwing up or passing out. Fortunately, a...
![]()
How #Cancerland Changed New York Fashion WeekNew York Fashion Week is a prestigious event that is held every year in the months of February and September. It shows off the latest fashion collections from renown designers, exhibited by the world’s most successful models. This year, AnoOno came together with #Cancerland, a U.S. non-profit...
![]()
Pregnancy Does Not Affect Breast Cancer Recurrence, Study FindsThere is a fear among some survivors of breast cancer that having a baby can cause the cancer to come back. For a while, there was no hard evidence one way or the other, so this question could cloud the mind of some women. Only ten percent of young women who have been diagnosed with breast cancer go...
Nearby Providers
![]()
Dr. Jay Courtright M.D.7777 Forest Ln Dallas TX 75230![]()
Dr. Lee Drinkard MDLee Drinkard, Md, Facp Irving TX 75039![]()
Dr. Stephen E. Boswank M.D.4700 N GALLOWAY AVE MESQUITE TX 75150![]()
Larry Anderson, Jr.2201 Inwood Road Dallas Texas 75235![]()
Dr. Edward D Agura M.D.3535 Worth St Dallas TX 75246![]()
Dr. Maryada Srinivas Reddy M. D.310 E Highway 67 Duncanville TX 75137
Nearest Hospitals
BAYLOR HEART AND VASCULAR HOSPITALl
621 NORTH HALL STREET DALLAS TX 75226BAYLOR UNIVERSITY MEDICAL CENTERl
3500 GASTON AVE DALLAS TX 75246BAYLOR UNIVERSITY MEDICAL CENTERl
3500 GASTON AVE DALLAS TX 75246BAYLOR HEART AND VASCULAR HOSPITALl
621 NORTH HALL STREET DALLAS TX 75226TOLEDO HOSPITAL THEl
2142 NORTH COVE BOULEVARD TOLEDO OH 43606ST LUKE'S HOSPITALl
5901 MONCLOVA ROAD MAUMEE OH 43537